메뉴 건너뛰기
Journal of the American Academy of Dermatology
Volumn 55, Issue 3, 2006, Pages 537-538
Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials
Author keywords

[No Author keywords available]
Indexed keywords

FLUOROURACIL; IMIQUIMOD; IMMUNOMODULATING AGENT;
EID: 33746888686     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.030     Document Type: Article
Times cited : (52)
References (5)
  • 1
    • 17444394323 scopus 로고    scopus 로고
    • Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials
    • Korman N., Moy R., Ling M., Matheson R., Smith S., McKane S., et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 141 (2005) 467-473
    • (2005) Arch Dermatol , vol.141 , pp. 467-473
    • Korman, N.1    Moy, R.2    Ling, M.3    Matheson, R.4    Smith, S.5    McKane, S.6
  • 2
    • 2342450044 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials
    • Lebwohl M., Dinehart S., Whiting D., Lee P.K., Tawfik N., Jorizzo J., et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 50 (2004) 714-721
    • (2004) J Am Acad Dermatol , vol.50 , pp. 714-721
    • Lebwohl, M.1    Dinehart, S.2    Whiting, D.3    Lee, P.K.4    Tawfik, N.5    Jorizzo, J.6
  • 3
    • 0036845121 scopus 로고    scopus 로고
    • A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses
    • Stockfletch E., Meyer T., Benninghoff B., Salasche S., Papadopoulos L., Ulrich C., et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 138 (2002) 1498-1502
    • (2002) Arch Dermatol , vol.138 , pp. 1498-1502
    • Stockfletch, E.1    Meyer, T.2    Benninghoff, B.3    Salasche, S.4    Papadopoulos, L.5    Ulrich, C.6
  • 4
    • 4644304377 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
    • Szeimies R.M., Gerritsen M.J., Gupta G., Ortonne J.P., Serresi S., Bichel J., et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 51 (2004) 547-555
    • (2004) J Am Acad Dermatol , vol.51 , pp. 547-555
    • Szeimies, R.M.1    Gerritsen, M.J.2    Gupta, G.3    Ortonne, J.P.4    Serresi, S.5    Bichel, J.6
  • 5
    • 20544455903 scopus 로고    scopus 로고
    • The role of glycopeptides as part of empirical treatment of febrile neutropenic patients: a meta-analysis of randomized controlled trials
    • Vardakas K.Z., Samonis G., Chrysanthopoulou S.A., Bliziotis I.A., and Falagas M.E. The role of glycopeptides as part of empirical treatment of febrile neutropenic patients: a meta-analysis of randomized controlled trials. Lancet Infect Dis 5 (2005) 431-439
    • (2005) Lancet Infect Dis , vol.5 , pp. 431-439
    • Vardakas, K.Z.1    Samonis, G.2    Chrysanthopoulou, S.A.3    Bliziotis, I.A.4    Falagas, M.E.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.